Atopic Eczema — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Applying low-dose topical calcineurin inhibitor to previously affected sites twice weekly even when skin appears clear
Proactive maintenance therapy involves applying topical calcineurin inhibitors (Tacrolimus 0.1% or Pimecrolimus 1%) to previously affected sites twice weekly even during apparent remission, to prevent relapses. This approach has been shown to significantly reduce eczema flare frequency compared to reactive therapy (treating only when flares occur). The evidence supports long-term safety of this approach without increased skin cancer or infection risk. BAD and EADV guidelines recommend proactive TCI maintenance for frequently relapsing eczema. Proactive therapy can also be performed with topical corticosteroids but TCI avoidance of steroid atrophy makes them preferred for long-term maintenance.
Reference: BAD 2020 AD Guidelines; EADV 2022 EuroGuiDerm